Cite
Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018
MLA
Samuel Coenen, et al. “Oseltamivir for Coronavirus Illness: Post-Hoc Exploratory Analysis of an Open-Label, Pragmatic, Randomised Controlled Trial in European Primary Care from 2016 to 2018.” The British Journal of General Practice : The Journal of the Royal College of General Practitioners, vol. 70, no. 696, Mar. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c79a4669a3431a6ff189c681dbb91297&authtype=sso&custid=ns315887.
APA
Samuel Coenen, Alike W van der Velden, Theo J M Verheij, Emily Bongard, Daniela Cianci, Herman Goossens, Nina Gobat, Benjamin R. Saville, Muireann De Paor, Margareta Ieven, & Christopher C Butler. (2020). Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018. The British Journal of General Practice : The Journal of the Royal College of General Practitioners, 70(696).
Chicago
Samuel Coenen, Alike W van der Velden, Theo J M Verheij, Emily Bongard, Daniela Cianci, Herman Goossens, Nina Gobat, et al. 2020. “Oseltamivir for Coronavirus Illness: Post-Hoc Exploratory Analysis of an Open-Label, Pragmatic, Randomised Controlled Trial in European Primary Care from 2016 to 2018.” The British Journal of General Practice : The Journal of the Royal College of General Practitioners 70 (696). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c79a4669a3431a6ff189c681dbb91297&authtype=sso&custid=ns315887.